Literature DB >> 11854218

Dissociated linkage of cytokine-inducing activity and cytotoxicity to different domains of listeriolysin O from Listeria monocytogenes.

Chikara Kohda1, Ikuo Kawamura, Hisashi Baba, Takamasa Nomura, Yutaka Ito, Terumi Kimoto, Isao Watanabe, Masao Mitsuyama.   

Abstract

Listeriolysin O (LLO), a cholesterol-binding cytolysin of Listeria monocytogenes, exhibits cytokine-inducing and cytolytic activities. Because the cytolytic activity was abolished by cholesterol treatment but the cytokine-inducing activity was not, these activities appeared to be linked to different domains of the LLO molecule. In this study, we constructed recombinant full-length LLO (rLLO529) and various truncated derivatives and examined their cytolytic, cholesterol-binding, and gamma interferon (IFN-gamma)-inducing activities. rLLO529 exhibited both IFN-gamma-inducing and cytolytic activities. Four truncated rLLOs possessing different C termini, which did not exert either cytolytic or cholesterol-binding activity, stimulated IFN-gamma production in normal spleen cells. However, a truncated rLLO corresponding to domain 4 (rLLO416-529) did not exhibit IFN-gamma-inducing activity, whereas it did bind to immobilized cholesterol. In addition, though the hemolysis induced by rLLO529 was inhibited by rLLO416-529, such inhibition was not detected upon rLLO529-induced IFN-gamma production. These data indicated that domain 4 was responsible for binding of LLO to membrane cholesterol followed by oligomerization and pore formation by the entire LLO molecule. In contrast, the other part of LLO, corresponding to domain 1-3, was essential for IFN-gamma-inducing activity. These findings implied a novel aspect of the function of LLO as a bacterial modulin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11854218      PMCID: PMC127785          DOI: 10.1128/IAI.70.3.1334-1341.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  C-terminal amino acid residues are required for the folding and cholesterol binding property of perfringolysin O, a pore-forming cytolysin.

Authors:  Y Shimada; M Nakamura; Y Naito; K Nomura; Y Ohno-Iwashita
Journal:  J Biol Chem       Date:  1999-06-25       Impact factor: 5.157

2.  Induction of macrophage interleukin-1 production by Listeria monocytogenes hemolysin.

Authors:  H Tsukada; I Kawamura; T Fujimura; K Igarashi; M Arakawa; M Mitsuyama
Journal:  Cell Immunol       Date:  1992-03       Impact factor: 4.868

Review 3.  Epidemiology of human listeriosis.

Authors:  A Schuchat; B Swaminathan; C V Broome
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

4.  Neutralizing monoclonal antibodies against listeriolysin: mapping of epitopes involved in pore formation.

Authors:  A Darji; K Niebuhr; M Hense; J Wehland; T Chakraborty; S Weiss
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

5.  Nucleotide sequence of the listeriolysin gene from a Listeria monocytogenes serotype 1/2a strain.

Authors:  E Domann; T Chakraborty
Journal:  Nucleic Acids Res       Date:  1989-08-11       Impact factor: 16.971

6.  Pneumolysin, the thiol-activated toxin of Streptococcus pneumoniae, does not require a thiol group for in vitro activity.

Authors:  F K Saunders; T J Mitchell; J A Walker; P W Andrew; G J Boulnois
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

7.  A role in cell-binding for the C-terminus of pneumolysin, the thiol-activated toxin of Streptococcus pneumoniae.

Authors:  R H Owen; G J Boulnois; P W Andrew; T J Mitchell
Journal:  FEMS Microbiol Lett       Date:  1994-08-15       Impact factor: 2.742

8.  Induction of cytokine gene expression by listeriolysin O and roles of macrophages and NK cells.

Authors:  T Nishibori; H Xiong; I Kawamura; M Arakawa; M Mitsuyama
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

9.  Introduction of pAM beta 1 into Listeria monocytogenes by conjugation and homology between native L. monocytogenes plasmids.

Authors:  R K Flamm; D J Hinrichs; M F Thomashow
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

10.  Induction of protective T cells against Listeria monocytogenes in mice by immunization with a listeriolysin O-negative avirulent strain of bacteria and liposome-encapsulated listeriolysin O.

Authors:  Y Tanabe; H Xiong; T Nomura; M Arakawa; M Mitsuyama
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

View more
  22 in total

1.  Seeligeriolysin O, a cholesterol-dependent cytolysin of Listeria seeligeri, induces gamma interferon from spleen cells of mice.

Authors:  Yutaka Ito; Ikuo Kawamura; Chikara Kohda; Hisashi Baba; Takamasa Nomura; Terumi Kimoto; Isao Watanabe; Masao Mitsuyama
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

2.  Listeriolysin O derived from Listeria monocytogenes inhibits the effector phase of an experimental allergic rhinitis induced by ovalbumin in mice.

Authors:  K Yamamoto; I Kawamura; T Tominaga; T Nomura; J Ito; M Mitsuyama
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

3.  A listeriolysin O subunit vaccine is protective against Listeria monocytogenes.

Authors:  Christopher C Phelps; Stephen Vadia; Prosper N Boyaka; Sanjay Varikuti; Zayed Attia; Purnima Dubey; Abhay R Satoskar; Rodney Tweten; Stephanie Seveau
Journal:  Vaccine       Date:  2020-07-17       Impact factor: 3.641

4.  Listeria-derived ActA is an effective adjuvant for primary and metastatic tumor immunotherapy.

Authors:  Laurence M Wood; Zhen-Kun Pan; Vafa Shahabi; Yvonne Paterson
Journal:  Cancer Immunol Immunother       Date:  2010-03-06       Impact factor: 6.968

5.  Evaluation of the safety and adjuvant effect of a detoxified listeriolysin O mutant on the humoral response to dengue virus antigens.

Authors:  K G Hernández-Flores; A L Calderón-Garcidueñas; G Mellado-Sánchez; R Ruiz-Ramos; L A Sánchez-Vargas; P Thomas-Dupont; I Y Izaguirre-Hernández; J Téllez-Sosa; J Martínez-Barnetche; L Wood; Y Paterson; L Cedillo-Barrón; O López-Franco; H Vivanco-Cid
Journal:  Clin Exp Immunol       Date:  2017-01-19       Impact factor: 4.330

6.  Immunization with genetic toxoids of the Arcanobacterium pyogenes cholesterol-dependent cytolysin, pyolysin, protects mice against infection.

Authors:  B Helen Jost; Hien T Trinh; J Glenn Songer; Stephen J Billington
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

7.  Differences in gamma interferon production induced by listeriolysin O and ivanolysin O result in different levels of protective immunity in mice infected with Listeria monocytogenes and Listeria ivanovii.

Authors:  Terumi Kimoto; Ikuo Kawamura; Chikara Kohda; Takamasa Nomura; Kohsuke Tsuchiya; Yutaka Ito; Isao Watanabe; Taijin Kaku; Endang Setianingrum; Masao Mitsuyama
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

8.  Multiple mechanisms contribute to the robust rapid gamma interferon response by CD8+ T cells during Listeria monocytogenes infection.

Authors:  Elsa N Bou Ghanem; Denise S McElroy; Sarah E F D'Orazio
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

9.  Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculature.

Authors:  Paulo Cesar Maciag; Matthew M Seavey; Zhen-Kun Pan; Soldano Ferrone; Yvonne Paterson
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

Review 10.  Listeriolysin O as a strong immunogenic molecule for the development of new anti-tumor vaccines.

Authors:  Rui Sun; Yuqin Liu
Journal:  Hum Vaccin Immunother       Date:  2013-02-11       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.